A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder
Public ClinicalTrials.gov record NCT00206102. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Open Label, Flexible-dose, Parallel-group Evaluation of the Cataractogenic Potential of Quetiapine Fumarate (Seroquel) and Risperidone (Risperdal) in the Long Term Treatment of Participants With Schizophrenia or Schizoaffective Disorder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This Phase IV, randomized, parallel-group study is designed to evaluate the cataractogenic potential of quetiapine fumarate (SEROQUEL) compared with that of a putative non-cataractogenic antipsychotic medication risperidone (RISPERDAL). This study is being conducted to fulfill the SEROQUEL Phase IV commitment regarding evaluation of cataractogenic potential.
Study identification
- NCT ID
- NCT00206102
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 1,098 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2003 (Type not available)
- Primary completion
- Oct 2008 (Actual)
- Completion
- Oct 2008 (Actual)
- Last update posted
- Jan 14, 2013
2003 – 2008
United States locations
- U.S. sites
- 63
- U.S. states
- 23
- U.S. cities
- 63
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Little Rock | Arkansas | — | — |
| Research Site | Mabelvale | Arkansas | — | — |
| Research Site | Morrilton | Arkansas | — | — |
| Research Site | Anaheim | California | — | — |
| Research Site | Cerritos | California | — | — |
| Research Site | Chula Vista | California | — | — |
| Research Site | Garden Grove | California | — | — |
| Research Site | Long Beach | California | — | — |
| Research Site | Los Angeles | California | — | — |
| Research Site | Orange | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | San Marcos | California | — | — |
| Research Site | Denver | Colorado | — | — |
| Research Site | New Britian | Connecticut | — | — |
| Research Site | Boca Raton | Florida | — | — |
| Research Site | Boynton Beach | Florida | — | — |
| Research Site | Deerfield Beach | Florida | — | — |
| Research Site | Fort Lauderdale | Florida | — | — |
| Research Site | Orlando | Florida | — | — |
| Research Site | Pompano Beach | Florida | — | — |
| Research Site | Tampa | Florida | — | — |
| Research Site | West Palm Beach | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Augusta | Georgia | — | — |
| Research Site | Chicago | Illinois | — | — |
| Research Site | Joliet | Illinois | — | — |
| Research Site | Oak Brook Terrace | Illinois | — | — |
| Research Site | Schaumburg | Illinois | — | — |
| Research Site | Newton | Kansas | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | Metairie | Louisiana | — | — |
| Research Site | New Orleans | Louisiana | — | — |
| Research Site | Glen Burnie | Maryland | — | — |
| Research Site | Minneapolis | Minnesota | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Las Vegas | Nevada | — | — |
| Research Site | Cherry Hill | New Jersey | — | — |
| Research Site | Moorestown | New Jersey | — | — |
| Research Site | Paramus | New Jersey | — | — |
| Research Site | Stratford | New Jersey | — | — |
| Research Site | Brooklyn | New York | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Staten Island | New York | — | — |
| Research Site | Beechwood | Ohio | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Dayton | Ohio | — | — |
| Research Site | Lyndhurst | Ohio | — | — |
| Research Site | Medina | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Portland | Oregon | — | — |
| Research Site | Media | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Charleston | South Carolina | — | — |
| Research Site | Austin | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Houston | Texas | — | — |
| Research Site | Irving | Texas | — | — |
| Research Site | McKinney | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Midvale | Utah | — | — |
| Research Site | Arlington | Virginia | — | — |
| Research Site | Falls Church | Virginia | — | — |
| Research Site | Richmond | Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00206102, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 14, 2013 · Synced Oct 31, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00206102 live on ClinicalTrials.gov.